Maegan Deegan

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Tyrosine Kinase

Monoclonal Antibody

Top Venues

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Subotheni Thavaneswaran, Wei Yen Chan, Ray Asghari, John P Grady, Maegan Deegan, Valerie M Jansen, David M Thomas
Clinical Response to Seribantumab, an Anti-Human Epidermal Growth Factor Receptor-3 Immunoglobulin 2 Monoclonal Antibody, in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma Harboring an NRG1 Fusion. JCO precision oncology 6 (2022)